- Tytuł:
- A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR).
- Autorzy:
- Źródło:
- BMC cancer [BMC Cancer] 2024 Feb 01; Vol. 24 (1), pp. 163. Date of Electronic Publication: 2024 Feb 01.
- Typ publikacji:
- Clinical Trial Protocol; Journal Article
- MeSH Terms:
-
Carcinoma, Renal Cell*/radiotherapy
Carcinoma, Renal Cell*/drug therapy
Lutetium*/adverse effects
Lutetium*/therapeutic use
Radioisotopes*/adverse effects
Radioisotopes*/therapeutic use
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/radiotherapy
Antigens, Surface*/metabolism
Glutamate Carboxypeptidase II*/antagonists & inhibitorsRadiopharmaceuticals */adverse effectsRadiopharmaceuticals */therapeutic use
Humans ; Male ; Dipeptides/adverse effects ; Dipeptides/therapeutic use ; Heterocyclic Compounds, 1-Ring/adverse effects ; Heterocyclic Compounds, 1-Ring/therapeutic use ; Prospective Studies ; Quality of Life ; Treatment Outcome ; Tumor Microenvironment ; Female ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Multicenter Studies as Topic